Capillary Technologies India Limited (CAPILLARY)
Investor presentation- Revised
Investor Presentation - Q1 FY27
- Revenue from operations grew 43% YoY to ₹2,566 Mn; Adjusted EBITDA up 132% YoY to ₹440 Mn at 17% margin
- Normalised PAT ₹254 Mn at 10% margin; includes ₹333.9 Mn exceptional loss from cyber fraud
- Annual Recurring Revenue expanded to ₹10,266 Mn, up 43% YoY
- Organic NRR strong at 111%, inorganic NRR at 120% reflecting acquisition migration
- SessionM acquisition integration on track; $32M ARR planned with break-even in first year
- Subscription revenue grew 50% YoY to ₹2,425 Mn, now 94.5% of total revenue
- FY27 guidance reaffirmed: ₹10,650 Mn revenue and ₹1,720 Mn Adjusted EBITDA
- Headcount up 11% QoQ, focusing on AI/R&D and sales scaling
- Cyber fraud recovery efforts underway with legal actions and insurance claim in progress
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 CAPILLARY — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add CAPILLARY to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Capillary Technologies India Limited
Important.
The summary above is generated automatically from Capillary Technologies India Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.